MAEGAN FLYNN: Open Payments
NPI 1548770563 · TUPELO, MS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,011 in 57 payments from 13 companies in 2025. Trend: 2023 $1,813 · 2024 $1,707 · 2025 $1,011
Food & beverage: $1,011
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $416 |
| Amgen Inc. | 13 | $144 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 5 | $100 |
| Janssen Biotech, Inc. | 5 | $84 |
| PFIZER INC. | 2 | $48 |
| Organon LLC | 2 | $38 |
| Fresenius Kabi USA, LLC | 2 | $34 |
| Genentech USA, Inc. | 1 | $30 |
| Aurinia Pharma U.S., Inc. | 1 | $30 |
| GENZYME CORPORATION | 1 | $29 |
Products named: SKYRIZI, RINVOQ, TREMFYA, EVENITY, OFEV, XELJANZ, OTEZLA, Gazyva.
Industry payments across MS — which companies pay providers there.
